Pathways which are overexpressed in all patients, and in the subgroups of IFNhigh and IFNlow patients, all compared with healthy controls, analysed by gene set enrichment analysis
Pathway | No. of genes | All patients | IFNhigh | IFNlow |
---|---|---|---|---|
p Value | p Value | p Value | ||
IFN, interferon; NS, nonsignificant. | ||||
Pathways are shown with a p value <0.05, and a false discovery rate value <0.25. | ||||
Type I IFN-induced genes22 | 83 | 0.004 | <0.001 | NS |
IFNα-induced21 | 36 | 0.022 | <0.001 | NS |
IFNβ-induced21 | 51 | NS | <0.001 | NS |
Cytokine–cytokine receptor interaction | 129 | 0.006 | 0.005 | NS |
Neuroactive ligand–receptor interaction | 90 | 0.009 | NS | <0.001 |
Jak-STAT signalling pathway | 86 | 0.016 | 0.008 | NS |
Complement and coagulation cascades | 44 | 0.025 | 0.009 | NS |
Fatty acid metabolism | 41 | 0.027 | 0.015 | NS |
IFNγ-induced21 | 34 | NS | 0.019 | NS |